Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ·Healthcare·Biotechnology
$782.89
-1.28%
Mkt Cap $83.21B
Analyst Ratings
Buy
22
Hold
8
Sell
0
Price Target (130 analysts)
$836.00
Range $641.00 – $995.00
Implied Upside
+6.8%
Consensus $836.00 vs current $782.89